These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5567799)

  • 1. A rapid method for the estimation of drug-albumin affinity constants in human plasma.
    Solomon HM; Thomas GB
    Clin Pharmacol Ther; 1971; 12(3):445-8. PubMed ID: 5567799
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.
    Tillement JP; Zini R; d' Athis P; Vassent G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):307-13. PubMed ID: 4850753
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative interaction of warfarin and phenylbutazone with human serum albumin.
    Madsen BW; Ellis GM
    Biochem Pharmacol; 1981 Jun; 30(11):1169-73. PubMed ID: 7271816
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.
    Hervé F; Rajkowski K; Martin MT; Dessen P; Cittanova N
    Biochem J; 1984 Jul; 221(2):401-6. PubMed ID: 6206846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 7. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
    Wosilait WD
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vacancy affinity capillary electrophoresis to study competitive protein-drug binding.
    Erim FB; Kraak JC
    J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):205-10. PubMed ID: 9686888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of disease states on plasma protein binding of drugs.
    Reidenberg MM
    Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
    [No Abstract]   [Full Text] [Related]  

  • 11. Spectrophotofluorometric evidence of negatively cooperative binding of warfarin and phenylbutazone to human serum albumin.
    Madsen BW; Tearne PD
    Life Sci; 1980 Jan; 26(3):173-9. PubMed ID: 7360001
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of drug-protein binding.
    Gillette JR
    Ann N Y Acad Sci; 1973 Nov; 226():6-17. PubMed ID: 4588445
    [No Abstract]   [Full Text] [Related]  

  • 13. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 14. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.
    Frostell-Karlsson A; Remaeus A; Roos H; Andersson K; Borg P; Hämäläinen M; Karlsson R
    J Med Chem; 2000 May; 43(10):1986-92. PubMed ID: 10821711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New procedure for analysing drug binding data, exemplified by warfarin binding to human serum albumin.
    Vorum H; Bang D; Fisker K
    Biochem Pharmacol; 1993 Apr; 45(8):1715-20. PubMed ID: 8484809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences of serum albumins: I. Drug binding sites.
    Kosa T; Maruyama T; Otagiri M
    Pharm Res; 1997 Nov; 14(11):1607-12. PubMed ID: 9434282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of the lone tryptophan residue of rat alpha-foetoprotein in its drug-binding sites. Comparison with rat serum albumin.
    Hervé F; Martin MT; Rajkowski K; Dessen P; Cittanova N
    Biochem J; 1987 May; 244(1):81-5. PubMed ID: 2444212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic characterization of drug binding to human serum albumin by isothermal titration microcalorimetry.
    Aki H; Yamamoto M
    J Pharm Sci; 1994 Dec; 83(12):1712-6. PubMed ID: 7891299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.